LONDON - Pfizer Inc. has increased the pressure on Astrazeneca plc, publishing a presentation to the UK company's shareholders in which it outlines the strategic rationale for the proposed £63 billion (US$107 billion) takeover, and hints it is prepared to increase the offer.